Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R LOCKHART

Showing results (211-220 of 307) with videos related to

Pageof 31
Sort By:
Journal of Clinical Microbiology|June 10, 1998
Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolatesM A Pfaller, S R Lockhart, C Pujol, et al.
Eukaryotic Cell|March 5, 2013
Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infectionsLalitha Gade, Christina M Scheel, Cau D Pham, et al.
Journal of Clinical Microbiology|August 10, 2012
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011Shawn R Lockhart, Naureen Iqbal, Angela A Cleveland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2011
Transmission of Cryptococcus neoformans by Organ TransplantationJohn W Baddley, Denise C Schain, Asmita A Gupte, et al.
Antibiotics (Basel, Switzerland)|August 29, 2020
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida auris</i> InfectionsMahmoud Ghannoum, Maiken Cavling Arendrup, Vishnu P Chaturvedi, et al.
Clinical Microbiology Reviews|March 5, 2026
Contribution of fungal diseases to the U.S. chronic disease burdenRia R Ghai, Kaitlin Benedict, Tom M Chiller, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|June 30, 2026
Surveillance for Candida auris - United States, 2022-2024Jeremy A W Gold, Anna D Baker, Kaitlin Benedict, et al.
Journal of the Pediatric Infectious Diseases Society|May 7, 2020
Bloodstream Infections With Candida auris Among Children in Colombia: Clinical Characteristics and Outcomes of 34 CasesIndira Berrio, Diego H Caceres, Wilfrido Coronell R, et al.
Plos One|December 14, 2011
Whole genome sequence analysis of Cryptococcus gattii from the Pacific Northwest reveals unexpected diversityJohn D Gillece, James M Schupp, S Arunmozhi Balajee, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2018
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida aurisNathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, et al.
Pageof 31

Showing results (211-220 of 307) with videos related to

Sort By:
Pageof 31
Journal of Clinical Microbiology|June 10, 1998
Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolatesM A Pfaller, S R Lockhart, C Pujol, et al.
Eukaryotic Cell|March 5, 2013
Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infectionsLalitha Gade, Christina M Scheel, Cau D Pham, et al.
Journal of Clinical Microbiology|August 10, 2012
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011Shawn R Lockhart, Naureen Iqbal, Angela A Cleveland, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 12, 2011
Transmission of Cryptococcus neoformans by Organ TransplantationJohn W Baddley, Denise C Schain, Asmita A Gupte, et al.
Antibiotics (Basel, Switzerland)|August 29, 2020
Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida auris</i> InfectionsMahmoud Ghannoum, Maiken Cavling Arendrup, Vishnu P Chaturvedi, et al.
Clinical Microbiology Reviews|March 5, 2026
Contribution of fungal diseases to the U.S. chronic disease burdenRia R Ghai, Kaitlin Benedict, Tom M Chiller, et al.
Morbidity and Mortality Weekly Report. Surveillance Summaries (Washington, D.C. : 2002)|June 30, 2026
Surveillance for Candida auris - United States, 2022-2024Jeremy A W Gold, Anna D Baker, Kaitlin Benedict, et al.
Journal of the Pediatric Infectious Diseases Society|May 7, 2020
Bloodstream Infections With Candida auris Among Children in Colombia: Clinical Characteristics and Outcomes of 34 CasesIndira Berrio, Diego H Caceres, Wilfrido Coronell R, et al.
Plos One|December 14, 2011
Whole genome sequence analysis of Cryptococcus gattii from the Pacific Northwest reveals unexpected diversityJohn D Gillece, James M Schupp, S Arunmozhi Balajee, et al.
Antimicrobial Agents and Chemotherapy|December 12, 2018
The Fungal Cyp51-Specific Inhibitor VT-1598 Demonstrates <i>In Vitro</i> and <i>In Vivo</i> Activity against Candida aurisNathan P Wiederhold, Shawn R Lockhart, Laura K Najvar, et al.
Pageof 31